Photo from Envato
Over 3,000 drugs have been developed or repurposed using AI.
Digital transformation, particularly through AI, is anticipated to streamline drug discovery and development processes, enhancing efficiency and accelerating innovation.
A GlobalData survey revealed that a majority (82%) of pharmaceutical professionals believe digital transformation could significantly or moderately shorten development timelines.
This facilitates faster identification of potential drug candidates and the optimisation of clinical trial processes, said Urte Jakimaviciute, Senior Director of Market Research and Strategic Intelligence at GlobalData.
Meanwhile, over 3,000 drugs have been developed or repurposed using AI, most of which are still in the discovery or preclinical stages.
“The fact that most AI-driven drugs are in early stages suggests that more companies are increasingly turning to AI to explore and expand their drug pipelines,” Jakimaviciute added.
Join
Healthcare Asia Magazine
community
Since you’re here…
…there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.
We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.
Let us help you drive your business forward with a good partnership!
